Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Vaughan

Showing results (251-260 of 264) with videos related to

Pageof 27
Sort By:
The Journal of Cell Biology|November 2, 2005
Cytoplasmic dynein nomenclatureK Kevin Pfister, Elizabeth M C Fisher, Ian R Gibbons, et al.
Frontiers in Oncology|December 6, 2019
CPT1A/2-Mediated FAO Enhancement-A Metabolic Target in Radioresistant Breast CancerShujun Han, Ryan Wei, Xiaodi Zhang, et al.
Nature|August 4, 2016
A partially differentiated interior for (1) Ceres deduced from its gravity field and shapeR S Park, A S Konopliv, B G Bills, et al.
Radiation Research|September 4, 2008
NASA Radiation Biomarker Workshop, September 27-28, 2007Tore Straume, Sally A Amundson, William F Blakely, et al.
Iscience|December 5, 2022
PERIOD 2 regulates low-dose radioprotection via PER2/pGSK3β/β-catenin/Per2 loopAris T Alexandrou, Yixin Duan, Shanxiu Xu, et al.
British Journal of Cancer|April 23, 2005
HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivoL Pukac, P Kanakaraj, R Humphreys, et al.
Journal of Cell Science|March 2, 2023
StARD9 is a novel lysosomal kinesin required for membrane tubulation, cholesterol transport and Purkinje cell survivalFelicity R Sterling, Jon D'Amico, Alexandria M Brumfield, et al.
Blood|July 20, 2011
Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacySean H Lim, Andrew T Vaughan, Margaret Ashton-Key, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2015
Development and Characterization of Monoclonal Antibodies Specific for Mouse and Human Fcγ ReceptorsAlison L Tutt, Sonya James, Stéphanie A Laversin, et al.
Nature Communications|September 15, 2020
Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cellsDemet Candas-Green, Bowen Xie, Jie Huang, et al.
Pageof 27

Showing results (251-260 of 264) with videos related to

Sort By:
Pageof 27
The Journal of Cell Biology|November 2, 2005
Cytoplasmic dynein nomenclatureK Kevin Pfister, Elizabeth M C Fisher, Ian R Gibbons, et al.
Frontiers in Oncology|December 6, 2019
CPT1A/2-Mediated FAO Enhancement-A Metabolic Target in Radioresistant Breast CancerShujun Han, Ryan Wei, Xiaodi Zhang, et al.
Nature|August 4, 2016
A partially differentiated interior for (1) Ceres deduced from its gravity field and shapeR S Park, A S Konopliv, B G Bills, et al.
Radiation Research|September 4, 2008
NASA Radiation Biomarker Workshop, September 27-28, 2007Tore Straume, Sally A Amundson, William F Blakely, et al.
Iscience|December 5, 2022
PERIOD 2 regulates low-dose radioprotection via PER2/pGSK3β/β-catenin/Per2 loopAris T Alexandrou, Yixin Duan, Shanxiu Xu, et al.
British Journal of Cancer|April 23, 2005
HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivoL Pukac, P Kanakaraj, R Humphreys, et al.
Journal of Cell Science|March 2, 2023
StARD9 is a novel lysosomal kinesin required for membrane tubulation, cholesterol transport and Purkinje cell survivalFelicity R Sterling, Jon D'Amico, Alexandria M Brumfield, et al.
Blood|July 20, 2011
Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacySean H Lim, Andrew T Vaughan, Margaret Ashton-Key, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2015
Development and Characterization of Monoclonal Antibodies Specific for Mouse and Human Fcγ ReceptorsAlison L Tutt, Sonya James, Stéphanie A Laversin, et al.
Nature Communications|September 15, 2020
Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cellsDemet Candas-Green, Bowen Xie, Jie Huang, et al.
Pageof 27